Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea

INTRODUCTION: Globally, pneumococcal disease represents a significant burden. South Korea implemented the 7-valent pneumococcal conjugate vaccine (PCV7) in 2003, replaced with the 10-valent (PCV10) and 13-valent (PCV13) vaccine in 2010. In 2014, both vaccines were introduced in the national immuniza...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Autores principales: Kim, Hye-Young, Park, Seong-Beom, Kang, Eun-Sil, Lee, Sang-Min, Kim, Hyun-Jin, Wasserman, Matt
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993233/
https://ncbi.nlm.nih.gov/pubmed/32783576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1796426
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares